NIKA PHARMACEUTICALS, INC Balance Sheet
NIKA|4 years of annual SEC 10-K data (FY2021-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$17,934
FY2024
Cash
$2,083
Cash and equivalents
Total Debt
N/A
FY2024
Shareholder Equity
-$221,230
FY2024
NIKA PHARMACEUTICALS, INC had $17,934 in total assets with negative shareholders' equity of $221,230 as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -447.47 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
- Accrual-heavy earnings: Net income significantly exceeds operating cash flow
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Cash & Equivalents | $2.1K | $19.6K | $864 | $399 |
| Current Assets | $17.9K | $19.6K | $864 | $399 |
| Total Assets | $17.9K | $19.6K | $864 | $399 |
| Current Liabilities | $239.2K | $101.7K | $18.2K | $10.5K |
| Shareholders' Equity | -$221.2K | -$82.1K | -$17.3K | -$23.6K |